Lv5
860 积分 2024-02-12 加入
Efficacy and safety of efgartigimod versus intravenous immunoglobulin in early intervention of acetylcholine receptor antibody-positive impending myasthenic crisis: A retrospective cohort study
3小时前
待确认
A cost analysis of reductions in work productivity for MG patients and their caregivers by symptom severity
17天前
已完结
Astrocyte‐Derived Exosomes Contribute to Pathologies of Neuromyelitis Optica Spectrum Disorder in Rodent Model
1个月前
已完结
Biologic Drugs and Medicare Price Negotiation
1个月前
已完结
Rescue treatment with add-on efgartigimod in a patient with impending myasthenic crisis: a case report
1个月前
已完结
Biologic Drugs and Medicare Price Negotiation
2个月前
已完结
The real-world impact of corticosteroid-associated adverse events in myasthenia gravis: A patient-reported survey analysis
3个月前
已完结
Effects of efgartigimod treatment on humoral and cellular immune responses: analysis of T-cell-dependent antibody response in cynomolgus monkeys
4个月前
已完结
Efgartigimod efficacy and safety in refractory myasthenia gravis: UK’s first real-world experience
4个月前
已完结
ADAPT NXT: Fixed Cycles or Every‐Other‐Week IV Efgartigimod in Generalized Myasthenia Gravis
4个月前
已完结
皖公网安备34019202002308
